Cargando...
Crizanlizumab for the Prevention of Vaso-Occlusive Pain Crises in Sickle Cell Disease
Objective: To review the efficacy and safety of crizanlizumab (Adakveo) in the prevention of vaso-occlusive pain crises in sickle cell disease. Data Sources: An English-language literature search of PubMed, MEDLINE, and Ovid (1946 to January 2021) was completed using the terms crizanlizumab, SEG101,...
Gardado en:
| Publicado en: | J Pharm Technol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8255978/ https://ncbi.nlm.nih.gov/pubmed/34752581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/87551225211008460 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|